Publication | Closed Access

Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years

VaccinationVaccine SafetyHpv-16/18 As04-adjuvanted VaccineVaccine DevelopmentHuman Papillomavirus VaccinesVaccine TestingPediatricsVaccine EfficacyMedicineVaccine ResearchFour-year Follow-up